Steward Partners Investment Advisory’s Alterity Therapeutics ATHE Stock Holding History

Steward Partners Investment Advisory’s Portfolio ATHE Stock Details ATHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$32	Hold	6	–	–	﹤0.01%	4600
2026 Q1	$21	Hold	6	–	–	﹤0.01%	4383
2025 Q4	$18	Hold	6	–	–	﹤0.01%	4278
2025 Q3	$23	Hold	6	–	–	﹤0.01%	4225
2025 Q2	$25	Hold	6	–	–	﹤0.01%	4082
2025 Q1	$21	Hold	6	–	–	﹤0.01%	3991
2024 Q4	$20	Hold	6	–	–	﹤0.01%	3952
2024 Q3	$8	Hold	6	–	–	﹤0.01%	3724
2024 Q2	$11	Hold	6	–	–	﹤0.01%	3599
2024 Q1	$12	Hold	6	–	–	﹤0.01%	3552
2023 Q4	$15	Hold	6	–	–	﹤0.01%	3480
2023 Q3	$15	Hold	6	–	–	﹤0.01%	3363
2023 Q2	$17	Hold	6	–	–	﹤0.01%	3306
2023 Q1	$17	Hold	6	–	–	﹤0.01%	3292
2022 Q4	$21	Hold	6	–	–	﹤0.01%	3334
2022 Q3	$0	Hold	6	–	–	﹤0.01%	3224
2022 Q2	$0	Hold	6	–	–	﹤0.01%	3235
2022 Q1	$0	Hold	6	–	–	﹤0.01%	3278
2021 Q4	$0	Hold	6	–	–	﹤0.01%	3180
2021 Q3	$0	Hold	6	–	–	﹤0.01%	3157
2021 Q2	$0	Hold	6	–	–	﹤0.01%	7093
2021 Q1	$88	Hold	6	–	–	﹤0.01%	3391
2020 Q4	$0	Hold	6	–	–	﹤0.01%	2869
2020 Q3	$0	Hold	6	–	–	﹤0.01%	2732
2020 Q2	$0	Hold	6	–	–	﹤0.01%	2654
2020 Q1	$0	Hold	6	–	–	﹤0.01%	2484
2019 Q4	$0	Hold	6	–	–	﹤0.01%	2587
2019 Q3	$0	Buy	+6	New	+$67	﹤0.01%	2611

Other funds holding ATHE

TLCM

Twin Lakes Capital Management Redwood Shores, California $262M AUM 60.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

HWM

HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Steward Partners Investment Advisory's ATHE Position: Q2 2026 in Review

Steward Partners Investment Advisory held its Alterity Therapeutics (ATHE) position steady in Q2 2026 at 6 shares worth $32. The position accounts for ﹤0.01% of the portfolio, ranked #4600.

Steward Partners Investment Advisory first reported a position in ATHE in Q3 2019 and has held it in 28 quarters since. The position peaked at $88 in Q1 2021. 22 funds tracked by Wall St. Rank hold ATHE as of Q2 2026.

Steward Partners Investment Advisory held 6 shares of Alterity Therapeutics worth $32 as of Q2 2026.
Steward Partners Investment Advisory left its Alterity Therapeutics share count unchanged in Q2 2026.
Alterity Therapeutics made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #4600 holding.
Steward Partners Investment Advisory first reported a position in Alterity Therapeutics in Q3 2019 and has held it in 28 quarters since.
Steward Partners Investment Advisory's Alterity Therapeutics position peaked at $88 in Q1 2021.
22 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.